kabutan

SEIKAGAKU CORPORATION(4548) Summary

4548
TSE Prime
SEIKAGAKU CORPORATION
742
JPY
-5
(-0.67%)
Mar 13, 3:30 pm JST
4.65
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
45.0
PBR
0.55
Yield
4.04%
Margin Trading Ratio
16.63
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
743 JPY 4.66 USD
Previous Close Mar 12
747 JPY 4.69 USD
High Mar 13, 10:44 am
750 JPY 4.71 USD
Low Mar 13, 9:00 am
739 JPY 4.64 USD
Volume
116,600
Trading Value
0.09B JPY 0.54M USD
VWAP
743.79 JPY 4.67 USD
Minimum Trading Value
74,200 JPY 465 USD
Market Cap
0.04T JPY 0.27B USD
Number of Trades
201
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
Mid
1-Year Average
302
1-Year High Dec 2, 2025
1,012
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 92,700 506,300 5.46
Feb 27, 2026 86,900 482,000 5.55
Feb 20, 2026 66,400 1,598,400 24.07
Feb 13, 2026 192,800 1,586,500 8.23
Feb 6, 2026 123,400 1,560,700 12.65
Company Profile
SEIKAGAKU CORPORATION specializes in the development of products related to joint diseases. Its hyaluronic acid preparations are distributed through partnerships with Kaken Pharmaceutical and Santen Pharmaceutical.
Sector
Pharmaceuticals
SEIKAGAKU CORPORATION engages in the research, development, manufacturing, procurement, and sales of pharmaceuticals and LAL (Limulus Amebocyte Lysate) products, including endotoxin detection reagents. In its pharmaceutical business, the company focuses on joint function improving agents as its main product line, while also offering ophthalmic surgical aids and treatments for lumbar disc herniation. Additionally, the company manufactures pharmaceutical ingredients and provides contract manufacturing services for pharmaceuticals. In the LAL business, SEIKAGAKU CORPORATION offers endotoxin detection reagents and glucan measurement in vitro diagnostic products. The company has several subsidiaries both domestically and internationally, conducting pharmaceutical and medical device development in North America, as well as manufacturing and sales operations overseas.